Back

Safety and effectiveness of drug-coated balloon angioplasty in de novo coronary lesions: 6-month outcomes from a multicenter registry

30 August 2026 (13:15 - 13:45)
Organised by: Logo
Congress Presentation Part of: Drug-coated balloon or drug-eluting stent: tailoring de novo interventions Devices ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Ioannis Kachrimanidis

Ippokrateio General Hospital of Athens, Athens (Greece)

3 More presentations in this session

Presentation thumbnail
Temporal trends and clinical characteristics of drug-coated balloon angioplasty for de dovo coronary lesions: A five-year analysis from the ORPKI Registry
Professor T. Rakowski (Krakow, PL)
Abstract
Presentation thumbnail
Impact of routine angiographic follow-up on long-term clinical outcomes in patients with multivessel disease underwent successful percutaneous coronary intervention
Mrs Y. Lee (Seoul, KR)
Abstract
Presentation thumbnail
Impact of stepwise dual antiplatelet therapy de-escalation in patients with proximal LAD disease undergoing drug-coated balloon angioplasty: insights from the REC-CAGEFREE II trial
Professor C. Gao (Hefei, CN)
Abstract

Access the full session

Session thumbnail
Drug-coated balloon or drug-eluting stent: tailoring de novo interventions

The Event

Event poster

ESC Congress 2026

30 August 2026 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Lesion preparation as an independent determinant of outcomes after drug-coated balloon angioplasty: evidence from clinical, angiographic and functional assessment in observational cohort
19 February 2026
thumbnail
Congress Presentation
Results of percutaneous coronary intervention of unprotected left main coronary disease in octogenarian patients
3 September 2019
thumbnail
Congress Presentation
Head to head comparison of limus vs paclitaxel-coated balloons (DCBs) in the treatment of in-stent restenosis: a meta-analysis
1 September 2025
thumbnail
Congress Presentation
REC-CAGEFREE I - Drug-coated balloon angioplasty with rescue stenting versus intended stenting for the treatment of de novo coronary artery lesions: a multicenter, non-inferiority trial
2 September 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources